ArticleJAMA network open2025
Prenatal Exposure to Fine Particulate Matter Components and Autism Risk in Childhood.
Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pollutant Burden in Autism Spectrum Disorder: Mechanistic Convergence, Genetic Susceptibility, and Clinical Translation.Current issues in molecular biology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Prenatal and early-life exposure to fine particulate matter (PM2.5) has been associated with autism spectrum disorder (ASD), but the role of individual components and timing of exposure remains unclear. Objective: To examine associations between prenatal and first-year-of-life exposure to PM2.5 components and ASD diagnosis, and identify potentially sensitive periods during pregnancy. Design, Setting, and Participants: This cohort study conducted in Ontario, Canada, used administrative health data covering approximately 98% of births in the province. The cohort included singleton live births from Ontario hospitals between April 1, 2002, and December 31, 2022, with gestational age 36 to 42 weeks, birth weight 500 to 6800 g, maternal age 15 to 55 years, complete residential history, and provincial health insurance coverage. At least 18 months of follow-up was required for postnatal exposure analyses. Exposures: Biweekly concentrations of PM2.5 components (black carbon, dust, ammonium, nitrate, organic matter, sulfate, sea salt) and weekly NO2 and O3 from conception to age 36 weeks. Prenatal models were adjusted for postnatal exposure using annual averages. Pollutant levels were estimated using satellite data, chemical transport models, and ground-based measurements. Main Outcomes and Measures: ASD diagnosis by age 5 years. Cox proportional hazards models were used to assess associations, and distributed lag nonlinear models identified sensitive exposure windows. Results: Among 2 183 324 births (mean [SD] maternal age, 30.5 [5.4] years; mean [SD] gestational age at birth, 39.2 [1.1] weeks; 1 152 040 female infants [48.9%]), prenatal exposure to PM2.5, sulfate (SO42-), and ammonium (NH4+), and postnatal exposure to ozone (O3), were associated with ASD. Hazard ratios (HRs) per 1-IQR increase for SO42- were 1.15 (95% CI, 1.06-1.25) and for NH4+ was 1.12 (95% CI, 1.01-1.23). PM2.5 mass excluding SO42- and NH4+ during their respective critical windows was not associated with ASD (HR, 1.04; 95% CI, 0.92-1.19). O3 exposure during weeks 26 to 30 (HR, 1.03; 95% CI, 1.00-1.05) and over the first year (HR, 1.09; 95% CI, 1.01-1.17) was also associated with ASD. Conclusions and Relevance: In this large cohort study, prenatal exposure to specific PM2.5 components and postnatal O3 exposure were associated with ASD risk. The second and third trimesters may represent sensitive exposure windows. These findings support further research on air pollution's role in ASD etiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.